Nasdaq-listed VivoPower raises $19M to expand its XRP treasury strategy, strengthening long-term digital asset holdings amid growing corporate adoption. Nasdaq-listed VivoPower has taken a significant step in its digital asset strategy. The company states it has successfully obtained a further common stock offering in the sum of $19 million. The shares were trading at $6.05, […] The post Nasdaq’s VivoPower Expands XRP Treasury with $19M appeared first on Live Bitcoin News.Nasdaq-listed VivoPower raises $19M to expand its XRP treasury strategy, strengthening long-term digital asset holdings amid growing corporate adoption. Nasdaq-listed VivoPower has taken a significant step in its digital asset strategy. The company states it has successfully obtained a further common stock offering in the sum of $19 million. The shares were trading at $6.05, […] The post Nasdaq’s VivoPower Expands XRP Treasury with $19M appeared first on Live Bitcoin News.

Nasdaq’s VivoPower Expands XRP Treasury with $19M

Nasdaq-listed VivoPower raises $19M to expand its XRP treasury strategy, strengthening long-term digital asset holdings amid growing corporate adoption.

Nasdaq-listed VivoPower has taken a significant step in its digital asset strategy. The company states it has successfully obtained a further common stock offering in the sum of $19 million. The shares were trading at $6.05, higher than the previous market close, indicating strong interest from investors. The new capital will be used to acquire, manage and hold XRP long-term.

VivoPower Strengthens XRP Strategy with New Capital Raise

According to the official announcement, VivoPower allocated new common shares at premium valuation. The deployment yielded gross proceeds of $19 million, further bolstering its financial standing for the expansion of the crypto treasury. The equity round follows a previous Regulation S offering, led by His Royal Highness Prince Abdulaziz bin Turki bin Talal Al Saud.

Related Reading: Ripple Veteran Hands Off CTO Duties, Pivots to XRPL Projects | Live Bitcoin News

The company explained that the transaction was done under a registration statement under Form F-1. It is effective as ordered by the U.S. Securities and Exchange Commission on May 27, 2025. The offering was made by a written prospectus, which was subsequently filed with the SEC. VivoPower also noted that the announcement is not a solicitation to buy or sell any securities.

The company’s strategy demonstrates its long-term commitment to the Ripple native token. Officials have mentioned XRP as a treasury asset for acquisition, holding and liquidity management. The theme is building a diversified reserve consistent with the recent U.S. legislation for digital asset treasuries. This framework has provided a way for companies like VivoPower to learn to tap into regulated crypto adoption with a stronger confidence base.

Nature’s Miracle Holding Inc is another example of corporate adoption of XRP. The company, which is active in the vertical farming and agricultural technology industry, recently added XRP to its payments and treasury functions. Its CEO, James Li, unveiled the strategy at OTCQB Venture Virtual Investor Conference in August 2025.

Corporate Moves Reflect Growing XRP Adoption

Industry experts emphasise that these announcements signal an emerging trend of corporate adoption of XRP. Regulatory clarity in the United States has spurred the treasury expansion of one crypto company, VivoPower, and the integration of Nature’s Miracle into the payment system of another, BitValent. This regulatory change has increased the number of companies looking to balance their balance sheets with assets based on the blockchain.

At the same time, XRP continues to be defined as a digital asset for market utility. Impervious to hacks, virtual settlements, payment and treasury applications are becoming appealing to firms that wish to be efficient and transparent. It is expected that more companies traded on NASDAQ could follow such steps in the near future.

Still, market observers are also tempted to include potential risks. Volatility, compliance costs and long-term liquidity strategies raise concerns. Critics state that corporations need to balance innovation and the prudent oversight of exposure to digital assets.

Despite these concerns, the path is obvious. The use of blockchain treasuries in corporations is growing, and XRP is one of the most popular options for treasuries. If the trend is to be accelerated, it could change the way that companies manage reserves and payments, not to mention the liquidation of assets, in the next downturn.

The post Nasdaq’s VivoPower Expands XRP Treasury with $19M appeared first on Live Bitcoin News.

Market Opportunity
XRP Logo
XRP Price(XRP)
$2.0636
$2.0636$2.0636
-1.56%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23